Burning Rock Biotech Limited (BNR)
NASDAQ: BNR · Real-Time Price · USD
14.61
-0.99 (-6.35%)
Oct 16, 2026, 9:48 AM EDT - Market open
Burning Rock Biotech Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 500.64 | 539.57 | 515.82 | 537.44 | 563.24 | 507.86 |
Revenue Growth | -6.65% | 4.60% | -4.02% | -4.58% | 10.90% | 18.13% |
Gross Profit Gross Profit Growth | 373.23 | 402.91 | 362.4 | 363.23 | 380.04 | 364.15 |
Operating Income Operating Income Growth | -65.02 | -54.85 | -322.43 | -669.32 | -980.41 | -797.06 |
Net Income Net Income Growth | -68.03 | -55.35 | -346.63 | -653.69 | -971.23 | -796.7 |
Earnings Per Share EPS Growth | -6.42 | -5.21 | -33.67 | -63.84 | -93.47 | -76.45 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Central Laboratory Channel Central Laboratory Channel Growth | 150.04 | 159.99 | 175.65 | 232.81 | 314.77 | 319.35 |
In-Hospital Channel In-Hospital Channel Growth | 223.76 | 224.04 | 224.49 | 188.7 | 175.3 | 165.12 |
Pharma Research and Development Channel Pharma Research and Development Channel Growth | 126.84 | 155.54 | 115.68 | 115.92 | 73.17 | 23.39 |
Total Total Growth | 500.64 | 539.57 | 515.82 | 537.44 | 563.24 | 507.86 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 416.82 | 480.79 | 525.99 | 628.5 | 907.55 | 1,497 |
Total Debt Total Debt Growth | 45.11 | 43.12 | 52.32 | 12.32 | 50.79 | 86.69 |
Net Cash (Debt) Net Cash Growth | 371.71 | 437.67 | 473.66 | 616.18 | 856.76 | 1,410 |
Net Cash Growth | -10.13% | -7.60% | -23.13% | -28.08% | -39.25% | -36.35% |
Net Cash Per Share Net Cash Per Share Growth | 35.09 | 41.17 | 46.02 | 60.18 | 82.45 | 135.33 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -12.22 | -28.44 | -92.26 | -255.78 | -456.81 | -477.89 |
Capital Expenditures CapEx Growth | -5.25 | -5.25 | -5.42 | -8.1 | -70.29 | -210.92 |
Free Cash Flow Free Cash Flow Growth | -17.47 | -33.69 | -97.68 | -263.89 | -527.1 | -688.81 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 74.55% | 74.67% | 70.26% | 67.58% | 67.47% | 71.70% |
Operating Margin | -12.99% | -10.17% | -62.51% | -124.54% | -174.07% | -156.94% |
Pretax Margin | -13.27% | -9.97% | -66.06% | -121.19% | -172.08% | -156.70% |
Profit Margin | -13.59% | -10.26% | -67.20% | -121.63% | -172.44% | -156.87% |
FCF Margin | -3.49% | -6.24% | -18.94% | -49.10% | -93.58% | -135.63% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PS Ratio | 2.23 | 2.81 | 0.98 | 1.29 | 2.90 | 12.46 |